BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35330578)

  • 1. [The value of OLGA staging system in risk assessment of gastric precancerous states and precancerous lesions].
    Wang XT; Han F; Wang C; Lyu B
    Zhonghua Yi Xue Za Zhi; 2022 Mar; 102(12):853-857. PubMed ID: 35330578
    [No Abstract]   [Full Text] [Related]  

  • 2. The application of new gastric cancer screening score system for gastric cancer screening and risk assessment of gastric precancerous lesions in China.
    Wang X; Zhang Q; Han F; Wu Y
    Scand J Gastroenterol; 2023 Jan; 58(1):34-37. PubMed ID: 35868004
    [No Abstract]   [Full Text] [Related]  

  • 3. Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment.
    Rugge M; Fassan M; Pizzi M; Farinati F; Sturniolo GC; Plebani M; Graham DY
    World J Gastroenterol; 2011 Nov; 17(41):4596-601. PubMed ID: 22147965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
    Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
    Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OLGA Gastritis Staging for the Prediction of Gastric Cancer Risk: A Long-term Follow-up Study of 7436 Patients.
    Rugge M; Genta RM; Fassan M; Valentini E; Coati I; Guzzinati S; Savarino E; Zorzi M; Farinati F; Malfertheiner P
    Am J Gastroenterol; 2018 Nov; 113(11):1621-1628. PubMed ID: 30333540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients.
    Rugge M; Meggio A; Pravadelli C; Barbareschi M; Fassan M; Gentilini M; Zorzi M; Pretis G; Graham DY; Genta RM
    Gut; 2019 Jan; 68(1):11-17. PubMed ID: 29306868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Operative link on gastritis assessment stage is an appropriate predictor of early gastric cancer.
    Zhou Y; Li HY; Zhang JJ; Chen XY; Ge ZZ; Li XB
    World J Gastroenterol; 2016 Apr; 22(13):3670-8. PubMed ID: 27053859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of operative link for gastritis assessment, operative link on gastric intestinal metaplasia assessment, and TAIM stagings among men with atrophic gastritis.
    Nieminen AA; Kontto J; Puolakkainen P; Virtamo J; Kokkola A
    World J Gastroenterol; 2020 Jun; 26(24):3447-3457. PubMed ID: 32655268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis.
    Capelle LG; de Vries AC; Haringsma J; Ter Borg F; de Vries RA; Bruno MJ; van Dekken H; Meijer J; van Grieken NC; Kuipers EJ
    Gastrointest Endosc; 2010 Jun; 71(7):1150-8. PubMed ID: 20381801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum pepsinogen levels and OLGA/OLGIM staging in the assessment of atrophic gastritis types.
    Ogutmen Koc D; Bektas S
    Postgrad Med J; 2022 Jun; 98(1160):441-445. PubMed ID: 33380437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lesions indefinite for intraepithelial neoplasia and OLGA staging for gastric atrophy.
    Fassan M; Pizzi M; Farinati F; Nitti D; Zagonel V; Genta RM; Rugge M
    Am J Clin Pathol; 2012 May; 137(5):727-32. PubMed ID: 22523210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study.
    Rugge M; de Boni M; Pennelli G; de Bona M; Giacomelli L; Fassan M; Basso D; Plebani M; Graham DY
    Aliment Pharmacol Ther; 2010 May; 31(10):1104-11. PubMed ID: 20180784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the angulus biopsy for the detection of gastric preneoplastic conditions and gastric cancer risk assessment.
    Varbanova M; Wex T; Jechorek D; Röhl FW; Langner C; Selgrad M; Malfertheiner P
    J Clin Pathol; 2016 Jan; 69(1):19-25. PubMed ID: 26163538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic scoring system for gastric atrophy and intestinal metaplasia: correlation with OLGA and OLGIM staging: a single-center prospective pilot study in Korea.
    Na HK; Choi KD; Park YS; Kim HJ; Ahn JY; Lee JH; Jung KW; Kim DH; Song HJ; Lee GH; Jung HY
    Scand J Gastroenterol; 2022 Sep; 57(9):1097-1104. PubMed ID: 35387540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Gastritis and Gastric Cancer Risk in the Chilean Population Using the OLGA System.
    Bellolio E; Riquelme I; Riffo-Campos AL; Rueda C; Ferreccio C; Villaseca M; Brebi P; Muñoz S; Araya JC
    Pathol Oncol Res; 2019 Jul; 25(3):1135-1142. PubMed ID: 30467699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OLGA and OLGIM stage distribution according to age and Helicobacter pylori status in the Korean population.
    Nam JH; Choi IJ; Kook MC; Lee JY; Cho SJ; Nam SY; Kim CG
    Helicobacter; 2014 Apr; 19(2):81-9. PubMed ID: 24617667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biopsy strategies for endoscopic screening of pre-malignant gastric lesions.
    Zhang M; Liu S; Hu Y; Bao HB; Meng LN; Wang XT; Xu Y; Zhao J; Lu B
    Sci Rep; 2019 Oct; 9(1):14909. PubMed ID: 31624309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of OLGA and OLGIM staging systems in the risk assessment of gastric cancer: a systematic review and meta-analysis.
    Yue H; Shan L; Bin L
    Gastric Cancer; 2018 Jul; 21(4):579-587. PubMed ID: 29460004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric cancer prevention targeted on risk assessment: Gastritis OLGA staging.
    Rugge M; Sugano K; Scarpignato C; Sacchi D; Oblitas WJ; Naccarato AG
    Helicobacter; 2019 Apr; 24(2):e12571. PubMed ID: 30773732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of the Angulus Biopsy on the Detection of Staging and the Grading of Chronic Gastritis.
    Khomeriki SG; Bordin DS; Khomeriki NM; Parfenchikova EV; Nikolskaya KA; Ivanova VA; Chebotareva MV; Gretskaya ML; Voynovan IN; Kiriukova MA; Livzan MA; Khatkov IE
    Diagnostics (Basel); 2023 Sep; 13(18):. PubMed ID: 37761296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.